Skip to main content
. Author manuscript; available in PMC: 2012 Jul 25.
Published in final edited form as: Physiol Behav. 2011 May 1;104(1):111–116. doi: 10.1016/j.physbeh.2011.04.048

Figure 3. Changes in fructose intake following administration of dopamine receptor antagonists.

Figure 3

All data depicted as a reduction from baseline intake referring to vehicle injection (set at 1.0 or 100% on y-axis). A. Fructose intake was significantly reduced by SCH23390. B. Raclopride reduced fructose intake in FCHE rats, but failed to reduce intake in HFHE or Chow rats at any dose. * p<0.05; **p<0.01; *** p<0.001 compared to vehicle.